Codexis, Inc. Equity-NMS: CDXS

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$2.35
Open :	$2.35
Today's high :	$2.5
Today's low :	$2.35
52W low :	$1.9
52W high :	$6.08
1Y :	-24.24%
5Y :	-79.06%
EPS(TTM): :	-0.8
Shares O/S :	90.27 M
Market cap :	224.77 M

What is the share price of Codexis, Inc. today?

Codexis, Inc. (CDXS) share price as of September 19, 2025, is $2.49. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Codexis, Inc.?

Yes, Indian Investors can invest in the Codexis, Inc. (CDXS) Share by opening an international trading account with Angel One.

How can I purchase Codexis, Inc. shares in India?

Purchasing Codexis, Inc. (CDXS) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Codexis, Inc. (CDXS) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Codexis, Inc.?

Yes, you can purchase fractional shares of Codexis, Inc. (CDXS) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Codexis, Inc.?

The market capitalization of Codexis, Inc. on September 19, 2025, is $224.77 M.

In which sector Codexis, Inc. belongs?

Codexis, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Codexis, Inc. stocks?

In order to invest in Codexis, Inc. (CDXS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.